Cargando…
Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
INTRODUCTION: Patients with type 2 diabetes are at risk of microvascular and macrovascular complications. Intensive glycaemic control, especially in patients with short duration of diabetes, is the mainstay of management of type 2 diabetes to lower the risk of complications. However, despite the imp...
Autores principales: | Kim, Nam Hoon, Lim, Soo, Kwak, Soo Heon, Moon, Min Kyong, Moon, Jun Sung, Lee, Yong-ho, Cho, Ho Chan, Lee, Juneyoung, Kim, Sin Gon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157558/ https://www.ncbi.nlm.nih.gov/pubmed/30249630 http://dx.doi.org/10.1136/bmjopen-2018-022448 |
Ejemplares similares
-
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020) -
Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study
por: Lim, Soo, et al.
Publicado: (2020) -
AXEL-2016: Introduction to Particle Accelerators
Publicado: (2016) -
Obituary: Axel Rethwilm (1959–2014)
por: Berkhout, Ben, et al.
Publicado: (2014) -
Axel Wenner-Gren : el vikingo que llegó del frío
por: Bolaños Guerra, Santiago
Publicado: (2008)